Skip to main content

Month: January 2021

Blueberries Medical Closes $1M Strategic Financing Led by a Leading Latin American Private Equity Group with Extensive International Cannabis Industry Expertise; Appoints Facundo Garretón as Chairman & Interim CEO

TORONTO, Jan. 20, 2021 (GLOBE NEWSWIRE) — Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) (the “Company” or “Blueberries“), a Latin American licensed producer of medicinal cannabis and cannabis-derived products, is pleased to announce the completion of a non-brokered private placement for aggregate gross proceeds of C$1,000,000 (the “Offering”) from the sale of common shares (“Common Shares”) at a price of C$0.065 per Common Share.The Offering was led by FLA Ventures Ltd. (“FLA Ventures”), a private equity fund based in Buenos Aires, Argentina, which focuses on investments in established and growth-oriented Latin American businesses across a range of sectors, seeking to create and add strategic value, driving their economic growth and enhancing their performances. Blueberries is pleased to welcome FLA Ventures...

Continue reading

Corporate Universe Engages PCAOB Auditor and Investor Relations Firm

NEW YORK, Jan. 20, 2021 (GLOBE NEWSWIRE) — Corporate Universe, Inc. (OTC: COUV) announced today that it has engaged Accell Audit and Compliance P.A., an SEC PCAOB Audit firm, to audit the Company’s year-end financial statements for calendar years 2019 and 2020 in order to become qualified as a fully audited company. The company has also engaged CORE IR (www.coreir.com) to provide a full suite of public relations and investor relations services, including the creating of a compliant investor relations page for its website and managing shareholder communications. In addition, Carbon-Ion Energy has engaged Sheppard Mullin as legal counsel, ensuring the completion of the merger within the coming weeks.Andrew Sispoidis, Carbon-Ion’s CEO commented, “Each of these practitioners provides an essential service, whether to further the...

Continue reading

Ehave, Inc. Closes 20/20 Global Transaction, Mycotopia Therapy Now Operating as a Publicly Traded Company with Intent to Focus on Psychedelic Sector

MIAMI, Jan. 20, 2021 (GLOBE NEWSWIRE) — Ehave, Inc. (OTC Pink: EHVVF) (the “Company”), a leader in digital therapeutics, announced today the Company has closed the transaction to sell 100% of its Mycotopia Therapy subsidiary to 20/20 Global Inc. (OTC Pink: TWGL). As a result of the transaction closing, Ehave controls approximately 75.77% of the outstanding shares of 20/20 Global. 20/20 Global Inc. plans to file with FINRA to change the name of the company to Mycotopia Therapy. Ehave, Inc. and 20/20 Global will file applicable 8k and 6k filings for the transaction with the SEC and SEDAR.Ehave Chairman and CEO Ben Kaplan will serve as Chairman and CEO of both Ehave and 20/20 Global. All payments have been made and stock certificates transferred to complete the transaction. In the future, Ehave management intends to present a plan...

Continue reading

AMMO, Inc. Announces Richard Childress, NASCAR Hall of Fame Member and Former NRA Director, Has Joined its Board of Directors

– Randy Luth Steps Down from the BoardSCOTTSDALE, Ariz., Jan. 20, 2021 (GLOBE NEWSWIRE) — AMMO, Inc. (Nasdaq: POWW ) (“AMMO” or the “Company”), a premier American ammunition and munition components manufacturer and technology leader, is pleased to announce that Richard Childress, owner of Richard Childress Racing, has joined AMMO’s Board of Directors.Former National Rifle Association (“NRA”) Board First Vice President and NASCAR driver, owner of Richard Childress Racing and Childress Vineyards and 2017 NASCAR Hall of Fame inductee, joined the Company’s Board effective January 19, 2021. “Richard brings more than five decades of incredibly successful business experience to our team, coupled with an unparalleled and well-earned national reputation based upon his stalwart support of our 2nd Amendment rights, service to the industry...

Continue reading

Liquid Media Announces AGM Results and New Director

VANCOUVER, British Columbia, Jan. 20, 2021 (GLOBE NEWSWIRE) — Liquid Media Group Ltd. (the “Company”, “Liquid Media” or “Liquid”) (Nasdaq: YVR) is pleased to announce that shareholders have voted in favor of all items of business brought before them at the Company’s Annual General Meeting of Shareholders (the “AGM”) held in Vancouver, British Columbia on Thursday, January 14, 2021. All of the nominees listed in the management proxy circular dated December 11, 2020 for the AGM were elected as directors of the Company.Detailed results of the vote for the election of the Class II directors held at the AGM are set out below.Liquid Media is pleased to announce the addition of Ronald W. Thomson to the Company’s Board of Directors, which was approved at the AGM. Earlier this month, Mr. Thomson was appointed CEO...

Continue reading

Imagin Medical Engages Torrey Hills Capital

VANCOUVER, British Columbia, and BOSTON, Jan. 20, 2021 (GLOBE NEWSWIRE) — via InvestorWire – Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) (FSE: DPD2) (“Imagin” or the “Company”) is pleased to announce that it has engaged San Diego Torrey Hills Capital, Inc. (“Torrey Hills Capital”), a Rancho Santa Fe, California-based investor relations firm, to provide market awareness and investor relations services to the Company, subject to acceptance by the Canadian Securities Exchange (“CSE”). Cliff Mastricola is the principal of Torrey Hills Capital and will be responsible for all activities related to Imagin.Torrey Hills Capital is a leading investor and financial public relations firm specializing in small and microcap companies and will increase awareness about Imagin through its established...

Continue reading

Evoke Pharma Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriter’s Option to Purchase Additional Shares

SOLANA BEACH, Calif., Jan. 20, 2021 (GLOBE NEWSWIRE) — Evoke Pharma, Inc. (Nasdaq: EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) disorders and diseases, announced today the completion of its follow-on offering of 5,750,000 shares of its common stock, including 750,000 shares of common stock sold pursuant to the underwriter’s full exercise of its option to purchase additional shares, at a price to the public of $2.50 per share. The gross proceeds from the offering were approximately $14.4 million, before underwriting discounts and commissions and estimated offering costs.Evoke intends to use the net proceeds from the offering for working capital and general corporate purposes, including funding commercialization activities, research and development activities, clinical trial expenditures,...

Continue reading

Myovant Sciences Announces New Employment Inducement Grants Under NYSE Rule 303A.08

BASEL, Switzerland, Jan. 20, 2021 (GLOBE NEWSWIRE) — Myovant Sciences (NYSE: MYOV), a healthcare company focused on redefining care for women and for men, today announced that it approved equity awards to David Marek in connection with his previously-announced employment by Myovant Sciences, Inc. (MSI) as its chief executive officer, which consisted of restricted stock units (RSUs) to acquire 223,076 common shares of Myovant Sciences Ltd. (Myovant), and an option to purchase 306,427 Myovant common shares. In addition, Myovant granted RSUs to acquire an aggregate of up to 87,300 Myovant common shares to eight other new employees joining MSI. The equity awards were granted to Mr. Marek and the other employees on January 15, 2021 under the 2020 Inducement Plan in accordance with NYSE’s Listed Company Manual Rule 303A.08.One-fourth...

Continue reading

SwarmConnect Launches Webpage Video Integration for Financial Advisory Firms

Tulsa, OK, Jan. 20, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — AppSwarm, Corp. (OTC: SWRM), a software development company and aggregator of mobile applications, announces new webpage integration feature for its ‘virtual advisor’ video conferencing solution.Webpage IntegrationSwarmConnect now offers customers the ability to utilize our application via iframe, a very powerful html tag that allows you to display any website within a website.You can utilize this new feature in several ways, such as:– Integrating the entire SwarmConnect product inside a web page utilizing your page for some additional User Interface (UI).– Embedding a single meeting on a web page at any size, alongside other web site or web applications UI.Virtual Advisory ServicesOne key area of focus for this feature will be the ability...

Continue reading

IEC Will Host Conference Call to Discuss Fiscal 2021 First Quarter Financial Results

NEWARK, N.Y., Jan. 20, 2021 (GLOBE NEWSWIRE) — IEC Electronics Corp. (Nasdaq: IEC) today announced that it will host a conference call on Wednesday, February 3, 2021 at 10:00 a.m. Eastern Time, to discuss its financial results for the fiscal first quarter of 2021, ended December 31, 2020.The conference call may be accessed in the U.S. and Canada by dialing toll-free (877) 407-9210. International callers may access the call by dialing (201) 689-8049.A replay of the teleconference will be available for 30 days after the call and may be accessed domestically by dialing (877) 481-4010 and international callers may dial (919) 882-2331. Callers must enter conference ID: 39521.To access the live webcast, log onto the IEC website at http://www.iec-electronics.com. The webcast can also be accessed at https://www.webcaster4.com/Webcast/Page/2149/39521....

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.